A case of endoscopic ultrasound-guided hepaticogastrostomy for obstructive jaundice caused by intraductal papillary mucinous neoplasm-associated pancreatobiliary fistula.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 24 12 2020
accepted: 30 01 2021
pubmed: 17 2 2021
medline: 29 6 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

Intraductal papillary mucinous neoplasm (IPMN) sometimes forms fistulas with other organs due to high pressure of pancreatic duct filled with huge amount of mucus. Pancreatobiliary fistula may cause obstructive jaundice due to the mucus and it is hard to manage the jaundice by endoscopic biliary stenting because of high viscosity of the bile. We report a case of IPMN with pancreatobiliary fistula managed by endoscopic ultrasound (EUS)-guided hepaticogastrostomy (HGS). The patient was 87 years old and presented with obstructive jaundice. As a transpapillary biliary stent was considered to have a risk of migration due to the absence of bile duct stenosis, a nasobiliary catheter was placed as an initial drainage. However, the catheter was frequently obstructed by mucus. The patient was intolerable for surgery because of his age. Considering the intrahepatic bile was serous, EUS-HGS was performed and jaundice improved successfully. This case study revealed that EUS-HGS might be a therapeutic option for obstructive jaundice caused by an IPMN-associated pancreatobiliary fistula.

Identifiants

pubmed: 33590462
doi: 10.1007/s12328-021-01355-0
pii: 10.1007/s12328-021-01355-0
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

893-898

Références

Ohhashi K, Murakami Y, Maruyama M, et al. Four cases of mucous secreting cancer of the pancreas with specific findings of the papilla of vater. Prog Dig Endosc. 1982;20:348–51.
Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57:339–43.
doi: 10.1136/gut.2007.129684
Maguchi H, Tanno S, Mizuno N, et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas. 2011;40:364–70.
doi: 10.1097/MPA.0b013e31820a5975
Kobayashi G, Fujita N, Noda Y, et al. Intraductal papillary mucinous neoplasms of the pancreas showing fistula formation into other organs. J Gastroenterol. 2010;45:1080–9.
doi: 10.1007/s00535-010-0263-z
Koizumi M, Kumagi T, Kuroda T, et al. Difficulty in management of intraductal papillary mucinous neoplasm-associated pancreatobiliary fistulas and the role of “pig-nose” appearance and intraductal ultrasonography in diagnosis. Endosc Int Open. 2016;4:E446–50.
doi: 10.1055/s-0042-102956
Barnardo A, Fotiadis N, Meenan J, et al. Endoscopic management of intraductal papillary mucinous tumors fistulating into the common bile duct. Gastrointest Endosc. 2007;66:1060–2.
doi: 10.1016/j.gie.2007.03.1061
Okamoto M, Kamitani Y, Iwamoto T, et al. Obstructive cholangitis by mucus from an intraductal papillary mucinous neoplasm with pancreatobiliary fistula treated by endoscopic septotomy and direct peroral cholangioscopy: a case report. Clin J Gastroenterol. 2019;12:495–9.
doi: 10.1007/s12328-019-00973-z
Goto N, Yoshioka M, Hayashi M, et al. Intraductal papillary-mucinous neoplasm of the pancreas penetrating to the stomach and the common bile duct. JOP. 2012;13:61–5.
pubmed: 22233949
Hong MY, Yu DW, Hong SG. Intraductal papillary mucinous neoplasm of the bile duct with gastric and duodenal fistulas. World J Gastrointest Endosc. 2014;16:328–33.
doi: 10.4253/wjge.v6.i7.328
Giovannini M, Moutardier V, Pesenti C, et al. Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy. 2001;33:898–900.
doi: 10.1055/s-2001-17324
Nam K, Kim DU, Lee TH, et al. Patient perception and preference of EUS-guided drainage over percutaneous drainage when endoscopic transpapillary biliary drainage fails: an international multicenter survey. Endosc Ultrasound. 2018;7:48–55.
doi: 10.4103/eus.eus_100_17
Iwashita T, Doi S, Yasuda I. Endoscopic ultrasound-guided biliary drainage: a review. Clin J Gastroenterol. 2014;7:94–102.
doi: 10.1007/s12328-014-0467-5
Nakai Y, Isayama H, Yamamoto N, et al. Safety and effectiveness of a long, partially covered metal stent for endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction. Endoscopy. 2016;48:1125–8.
doi: 10.1055/s-0042-116595
Okuno N, Hara K, Mizuno N, et al. Stent migration into the peritoneal cavity following endoscopic ultrasound-guided hepaticogastrostomy. Endoscopy. 2015;47:E311.
doi: 10.1055/s-0034-1392314
Miyano A, Ogura T, Yamamoto K, et al. Clinical impact of the intra-scope channel stent release technique in preventing stent migration during EUS-guided hepaticogastrostomy. J Gastrointest Surg. 2018;22:1312–8.
doi: 10.1007/s11605-018-3758-1
Ogura T, Okuda A, Miyano A, et al. Stent release within scope channel technique to prevent stent migration during EUS-guided hepaticogastrostomy (with video). Endosc Ultrasound. 2018;7:67–8.
pubmed: 29451173 pmcid: 5838732
Shima Y, Isayama H, Ito Y, et al. Crisscross anchor-stents to prevent metal stent migration during endoscopic ultrasound-guided hepaticogastrostomy. Endoscopy. 2014;46:E563.
doi: 10.1055/s-0034-1377945
Hirooka Y, Goto H, Itoh A, et al. Case of intraductal papillary mucinous tumor in which endosonography-guided fine-needle aspiration biopsy caused dissemination. J Gastroenterol Hepatol. 2003;18:1323–4.
doi: 10.1046/j.1440-1746.2003.03040.x
Yoon WJ, Daglilar ES, Fernández-del CC, et al. Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study. Endoscopy. 2014;46:382–7.
doi: 10.1055/s-0034-1364937

Auteurs

Takafumi Mie (T)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Takashi Sasaki (T)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Tsuyoshi Takeda (T)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Takaaki Furukawa (T)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Yuto Yamada (Y)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Akiyoshi Kasuga (A)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Masato Matsuyama (M)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Masato Ozaka (M)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

Naoki Sasahira (N)

Department of Hepato-Biliary-Pancreatic Medicine, Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan. naoki.sasahira@jfcr.or.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH